Is There an Upper Limit to Cardiopulmonary Bypass Times?
نویسندگان
چکیده
منابع مشابه
Is There an Upper Limit to Cardiopulmonary Bypass Times?
Background: There are no safe operations in cardiac surgery. Every operation can possibly go wrong. We therefore retrospectively evaluated all cardiac operations lasting more than 300 minutes of bypass time at our institution to evaluate outcome and factors relevant for perioperative mortality and morbidity. Methods: We retrospectively included patients receiving cardiac operations or operation...
متن کاملIs there an upper limit to black hole masses ?
We make a case for the existence for ultra-massive black holes (UMBHs) in the Universe, but argue that there exists a likely upper limit to black hole masses of the order of M ∼ 1010M⊙. We show that there are three strong lines of argument that predicate the existence of UMBHs: (i) expected as a natural extension of the observed black hole mass bulge luminosity relation, when extrapolated to th...
متن کاملThere Is an Upper Limit of Chromosome Size for Normal Development of an Organism
A clearly definable upper tolerance limit for chromosome arm length has been found. As a rule we postulate that, for normal development of an organism, the longest chromosome arm must not exceed half of the average length of the spindle axis at telophase. Above this length, fertility and viability of the carrier individuals become severely impaired due to increasingly incomplete separation of t...
متن کاملPercutaneous Cardiopulmonary Bypass to Total Cardiopulmonary Bypass to Repair an Acute Ventricular Septal Defect
This case report describes techniques involved in the conversion of femoral-femoral percutaneous cardiopulmonary bypass to femoral/superior vena cava-femoral cardiopulmonary bypass with integrated cardiotomy suckers and cardioplegia delivery system. The conversion was instituted in order to repair an acute ventricular septal defect secondary to a myocardial infarction without switching to a tra...
متن کاملTotal complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass.
BACKGROUND Activation of complement during revascularization of ischemic myocardium accentuates myocardial dysfunction. Soluble human complement receptor type 1 (sCR1) is a potent inhibitor of complement, as are heparin-bonded (HB) cardiopulmonary bypass (CPB) circuits. This study sought to determine whether total complement inhibition with the combination of sCR1 and HB-CPB limits damage durin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Circulation
سال: 2017
ISSN: 2641-2985
DOI: 10.17352/ac.000004